APA (7th ed.) Citation

DJH, T., CH, N., MD, M., R, L., & DQ, H. (2022). Clinical features and outcomes of NAFLD-related hepatocellular carcinoma - Authors' reply. The Lancet. Oncology, 23(6), e244. https://doi.org/10.1016/S1470-2045(22)00265-0

Chicago Style (17th ed.) Citation

DJH, Tan, Ng CH, Muthiah MD, Loomba R, and Huang DQ. "Clinical Features and Outcomes of NAFLD-related Hepatocellular Carcinoma - Authors' Reply." The Lancet. Oncology 23, no. 6 (2022): e244. https://doi.org/10.1016/S1470-2045(22)00265-0.

MLA (9th ed.) Citation

DJH, Tan, et al. "Clinical Features and Outcomes of NAFLD-related Hepatocellular Carcinoma - Authors' Reply." The Lancet. Oncology, vol. 23, no. 6, 2022, p. e244, https://doi.org/10.1016/S1470-2045(22)00265-0.